Diabetes and menopause aggravate age-dependent deterioration in arterial stiffness

Menopause

Volumn 21, Issue 11, 2014, Pages 1234-1238

  Shapiro, Yula ^a   Mashavi, Margarita ^a,b   Luckish, Ela ^a   Shargorodsky, Marina ^a,b  

^a WOLFSON MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Arterial stiffness; Menopause status; Type 2 diabetes mellitus

Indexed keywords

ALDOSTERONE; C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT; RENIN; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ADULT; ALDOSTERONE BLOOD LEVEL; ANALYZER; ARTERIAL STIFFNESS; ARTICLE; AUGMENTATION INDEX; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE METER; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MENOPAUSE; METABOLIC PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; PLASMA RENIN ACTIVITY; POSTMENOPAUSE; PREMENOPAUSE; PROTEIN BLOOD LEVEL; PULSE WAVE; TRIACYLGLYCEROL BLOOD LEVEL; AGED; AGING; ANALYSIS; BLOOD; COMPLICATION; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; AGED; AGING; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFLAMMATION; INSULIN; INSULIN RESISTANCE; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE; PULSE WAVE ANALYSIS; VASCULAR STIFFNESS;

EID: 84918568530     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/gme.0000000000000231     Document Type: Article

References (28)

1. Jousilahti P, Vartiainen E, Tuomilehto J, Puska P. Sex, age, cardiovascular risk factors, and coronary heart disease: A prospective follow-up study of 14 786 middle-aged men and women in Finland. Circulation 1999;99:1165-1172.
2. Jensen-Urstad K, Johansson J. Gender difference in age-related changes in vascular function. Intern Med 2001;250:29-36.
3. Gaspard UJ, Gottal JM, van den Brûle FA. Postmenopausal changes of lipid and glucose metabolism: A review of their main aspects. Maturitas 1995;21:171-178.
4. Narkiewicz K, Kjeldsen SE, Hedner T. Hypertension and cardiovascular disease in women: progress towards better understanding of genderspecific differences? Blood Press 2006;15:68-70.
5. Mascarenhas-Melo F, Marado D, Palavra F, et al. Diabetes abrogates sex differences and aggravates cardiometabolic risk in postmenopausal women. Cardiovasc Diabetol 2013;12:61.
6. Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance. An integrated index of vascular function? Circulation 2002;106:2085-2090.
7. Gomez-Marcos MA, Recio-Rodríguez JI, Patino-Alonso MC, et al. Yearly evolution of organ damage markers in diabetes or metabolic syndrome: data from the LOD-DIABETES study. Cardiovasc Diabetol 2011;10:9.
8. Huang G, Wang D, Zeb I, et al. Intra-thoracic fat, cardiometabolic risk factors, and subclinical cardiovascular disease in healthy, recently menopausal women screened for the Kronos Early Estrogen Prevention Study (KEEPS). Atherosclerosis 2012;221:198-205.
9. van Popele NM, Grobbee DE, Bots ML, et al. Association between arterial stiffness and atherosclerosis: The Rotterdam Study. Stroke 2001;32:454-460.
10. Weber T, Auer J, O'Rourke MF, et al. Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation 2004;109:184-189.
11. Laurent S, Boutouyrie P, Asmar R, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001;37:1236-1241.
12. Asmar RG, London GM, O'Rourke MF, Safar ME. Improvement in blood pressure, arterial stiffness and wave reflections with a very-lowdose perindopril/indapamide combination in hypertensive patient: A comparison with atenolol. Hypertension 2001;38;922-926.
13. Schiffrin EL. Vascular stiffening and arterial compliance. Am J Hypertens 2004;17:39-48.
14. O'Rourke M, Staessen JA. Clinical application of arterial stiffness definitions and reference values. Am J Hypertens 2002;15:426-444.
15. Rijpkema AH, van der Sanden AA, Ruijs AH. Effects of postmenopausal oestrogen-progestogen replacement therapy on serum lipids and lipoproteins: A review. Maturitas 1990;12:259-285.
16. Grodstein F, Stampfer MJ, Manson JE, et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996;335:453-461.
17. Grady D, Rubin SM, Petitti DB, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992;117:1016-1037.
18. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. J Am Med Assoc 1998;280:605-613.
19. Hsia J, Langer RD, Manson JE, et al. Conjugated equine estrogens and coronary heart disease: The Women's Health Initiative. Arch Intern Med 2006;166:357-365.
20. Miller VM, Duckles SP. Vascular actions of estrogens: Functional implications. Pharmacol Rev 2008;60:210-241.
21. Lam K-K, Lee Y-M, Hsiao G. Estrogen therapy replenishes vascular tetrahydrobiopterin and reduces oxidative stress in ovariectomized rats. Menopause 2006;13:294-302.
22. Serock MR, Wells AK, Khalil RA. Modulators of vascular sex hormone receptors and their effects in estrogen-deficiency states associated with menopause. Recent Pat Cardiovasc Drug Discov 2008;3:165-186.
23. Ushioda M, Makita K, Takamatsu K, Horiguchi F, Aoki D. Serum lipoprotein(a) dynamics before/after menopause and long-term effects of hormone replacement therapy on lipoprotein(a) levels in middle-aged and older Japanese women. Horm Metab Res 2006;38:581-586.
24. Sumino H, Ichikawa S, Itoh H, et al. Hormone replacement therapy decreases insulin resistance and lipid metabolism in Japanese postmenopausal women with impaired and normal glucose tolerance. Horm Res 2003;60:134-142.
25. Nishizaka MK, Zaman MA, Green SA, Renfroe KY, Calhoun DA. Impaired endothelium-dependent flow-mediated vasodilation in hypertensive subjects with hyperaldosteronism. Circulation 2004;109:2857-2861.
26. Romagni P, Rossi F, Guerrini L, Quirini C, Santiemma V. Aldosterone induces contraction of the resistance arteries in man. Atherosclerosis 2003;166:345-349.
27. Rocha R, Stier CT, Kifor I, et al. Aldosterone: A mediator of myocardial necrosis and renal arteriopathy. Endocrinology 2000;141:3871-3878.
28. Wehling M, Neylon CB, Fullerton M, Bobik A, Funder JW. Nongenomic effects of aldosterone on intracellular Ca2+ in vascular smooth muscle cells. Circ Res 1995;76:973-979.